Literature DB >> 21471526

Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AML.

Simon Haefliger1, Christiane Klebig, Kerstin Schaubitzer, Julian Schardt, Nikolai Timchenko, Beatrice U Mueller, Thomas Pabst.   

Abstract

Deregulation of the myeloid key transcription factor CEBPA is a common event in acute myeloid leukemia (AML). We previously reported that the chaperone calreticulin is activated in subgroups of AML patients and that calreticulin binds to the stem loop region of the CEBPA mRNA, thereby blocking CEBPA translation. In this study, we screened for additional CEBPA mRNA binding proteins and we identified protein disulfide isomerase (PDI), an endoplasmic reticulum (ER) resident protein, to bind to the CEBPA mRNA stem loop region. We found that forced PDI expression in myeloid leukemic cells in fact blocked CEBPA translation, but not transcription, whereas abolishing PDI function restored CEBPA protein. In addition, PDI protein displayed direct physical interaction with calreticulin. Induction of ER stress in leukemic HL60 and U937 cells activated PDI expression, thereby decreasing CEBPA protein levels. Finally, leukemic cells from 25.4% of all AML patients displayed activation of the unfolded protein response as a marker for ER stress, and these patients also expressed significantly higher PDI levels. Our results indicate a novel role of PDI as a member of the ER stress-associated complex mediating blocked CEBPA translation and thereby suppressing myeloid differentiation in AML patients with activated unfolded protein response (UPR).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21471526      PMCID: PMC3293752          DOI: 10.1182/blood-2010-08-304485

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.

Authors:  Danilo Perrotti; Vincenzo Cesi; Rossana Trotta; Clara Guerzoni; Giorgia Santilli; Kenneth Campbell; Angela Iervolino; Fabrizio Condorelli; Carlo Gambacorti-Passerini; Michael A Caligiuri; Bruno Calabretta
Journal:  Nat Genet       Date:  2001-12-20       Impact factor: 38.330

Review 3.  The protein disulphide-isomerase family: unravelling a string of folds.

Authors:  D M Ferrari; H D Söling
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

Review 4.  The human protein disulphide isomerase family: substrate interactions and functional properties.

Authors:  Lars Ellgaard; Lloyd W Ruddock
Journal:  EMBO Rep       Date:  2005-01       Impact factor: 8.807

5.  PU.1 is regulated by NF-kappaB through a novel binding site in a 17 kb upstream enhancer element.

Authors:  N Bonadies; Ch Neururer; A Steege; S Vallabhapurapu; T Pabst; B U Mueller
Journal:  Oncogene       Date:  2009-12-07       Impact factor: 9.867

6.  Protein disulfide isomerase suppresses the transcriptional activity of NF-kappaB.

Authors:  Toshio Higuchi; Yoshihiro Watanabe; Iwao Waga
Journal:  Biochem Biophys Res Commun       Date:  2004-05-21       Impact factor: 3.575

Review 7.  C/EBPalpha induces PU.1 and interacts with AP-1 and NF-kappaB to regulate myeloid development.

Authors:  Alan D Friedman
Journal:  Blood Cells Mol Dis       Date:  2007-07-31       Impact factor: 3.039

8.  Phosphorylation of C/EBPalpha inhibits granulopoiesis.

Authors:  Sarah E Ross; Hanna S Radomska; Bo Wu; Pu Zhang; Jonathon N Winnay; Laszlo Bajnok; Wendy S Wright; Fred Schaufele; Daniel G Tenen; Ormond A MacDougald
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

9.  CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors.

Authors:  H S Radomska; C S Huettner; P Zhang; T Cheng; D T Scadden; D G Tenen
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

Review 10.  The mammalian unfolded protein response.

Authors:  Martin Schröder; Randal J Kaufman
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

View more
  23 in total

1.  Requirements for mouse mammary tumor virus Rem signal peptide processing and function.

Authors:  Hyewon Byun; Nimita Halani; Yongqiang Gou; Andrea K Nash; Mary M Lozano; Jaquelin P Dudley
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Protein disulfide isomerase is required for platelet-derived growth factor-induced vascular smooth muscle cell migration, Nox1 NADPH oxidase expression, and RhoGTPase activation.

Authors:  Luciana A Pescatore; Diego Bonatto; Fábio L Forti; Amine Sadok; Hervé Kovacic; Francisco R M Laurindo
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

3.  JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia.

Authors:  C Zhou; E Martinez; D Di Marcantonio; N Solanki-Patel; T Aghayev; S Peri; F Ferraro; T Skorski; C Scholl; S Fröhling; S Balachandran; D L Wiest; S M Sykes
Journal:  Leukemia       Date:  2016-11-14       Impact factor: 11.528

Review 4.  The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies.

Authors:  B Luo; A S Lee
Journal:  Oncogene       Date:  2012-04-16       Impact factor: 9.867

5.  Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment.

Authors:  Shili Xu; Alexey N Butkevich; Roppei Yamada; Yu Zhou; Bikash Debnath; Roger Duncan; Ebrahim Zandi; Nicos A Petasis; Nouri Neamati
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

6.  Protein Disulfide Isomerase Superfamily in Disease and the Regulation of Apoptosis.

Authors:  C Grek; D M Townsend
Journal:  Endoplasmic Reticulum Stress Dis       Date:  2014-01

7.  Research perspective: potential role of nitazoxanide in ovarian cancer treatment. Old drug, new purpose?

Authors:  Nicola Di Santo; Jessie Ehrisman
Journal:  Cancers (Basel)       Date:  2013-09-10       Impact factor: 6.639

Review 8.  Drugging the unfolded protein response in acute leukemias.

Authors:  Behzad Kharabi Masouleh; Eric Chevet; Jens Panse; Edgar Jost; Michael O'Dwyer; Tim H Bruemmendorf; Afshin Samali
Journal:  J Hematol Oncol       Date:  2015-07-16       Impact factor: 17.388

Review 9.  ERO1-PDI Redox Signaling in Health and Disease.

Authors:  Vishwanath Jha; Tripti Kumari; Vijayprakash Manickam; Zahra Assar; Kirk L Olson; Jeong-Ki Min; Jaehyung Cho
Journal:  Antioxid Redox Signal       Date:  2021-07-13       Impact factor: 8.401

10.  Mechanistic Study of the Phytocompound, 2- β -D-Glucopyranosyloxy-1-hydroxytrideca-5,7,9,11-tetrayne in Human T-Cell Acute Lymphocytic Leukemia Cells by Using Combined Differential Proteomics and Bioinformatics Approaches.

Authors:  Jeng-Yuan Shiau; Shu-Yi Yin; Shu-Lin Chang; Yi-Jou Hsu; Kai-Wei Chen; Tien-Fen Kuo; Ching-Shan Feng; Ning-Sun Yang; Lie-Fen Shyur; Wen-Chin Yang; Tuan-Nan Wen
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-18       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.